featured
Impact and Effectiveness of mRNA BNT162b2 Vaccine Against SARS-CoV-2 Infections and COVID-19 Following a Nationwide Vaccination Campaign in Israel
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact and Effectiveness of mRNA BNT162b2 Vaccine Against SARS-CoV-2 Infections and COVID-19 Cases, Hospitalisations, and Deaths Following a Nationwide Vaccination Campaign in Israel: An Observational Study Using National Surveillance Data
Lancet 2021 May 15;397(10287)1819-1829, EJ Haas, FJ Angulo, JM McLaughlin, E Anis, SR Singer, F Khan, N Brooks, M Smaja, G Mircus, K Pan, J Southern, DL Swerdlow, L Jodar, Y Levy, S Alroy-PreisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.